Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

LKCM Small Capital Equity Fund Advisor Class (LKSAX)

20.17
Net Asset Value
-0.20%
1 Day
+6.55%
Year-to-Date
Overall Morningstar Rating
Small growth
Style or Category
No Load
Sales Expenses
1.22%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks to maximize long-term capital appreciation. The fund seeks to achieve its investment objective by investing under normal circumstances at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of smaller companies. The fund primarily chooses investments that Luther King Capital Management Corporation ("Adviser") believes are likely to have above-average growth in revenue and/or earnings and potential for above-average capital appreciation. Smaller companies are those with market capitalizations at the time of investment between $600 million and $4.5 billion.

Performance

1 month+9.74% 3 years-0.23%
3 months+0.15% 5 years+7.24%
1 year+0.01% Since inception+8.08%
Data through --

Peer Comparisonvs. Small growth

 LKSAXCategory
Performance 5-yr return+7.24%+14.42%
Expense ratio1.22%1.33%
Risk 5 year sharpe ratio0.460.75
Net assets$337.4M$846.2M
Average market cap$2.4B$2.9B
Average P/E25.624.6
Portfolio turnover62%62%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyLKCM
Fund manager & tenureJ. King / 22 Years
Minimal initial investment$2,000.00
Minimum IRA investment--

Holdings

U.S. stock99.02%
International stock0.98%
Fixed income0.00%
Cash0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 15.56%
Consumer service 15.38%
Energy 11.40%
Financial service 10.67%
Healthcare 9.43%
Top 10 Holdings
Portfolio weighting
TTWO Take-Two Interactive Software Inc2.42%
POOL Pool Corp2.14%
HCSG Healthcare Services Group Inc2.10%
EEFT Euronet Worldwide Inc2.09%
PRAH PRA Health Sciences Inc2.02%
VWR VWR Corp1.96%
FCN FTI Consulting Inc1.92%
EME EMCOR Group Inc1.89%
CRL Charles River Laboratories International Inc1.87%
OMCL Omnicell Inc1.82%